National Cancer Institute
The National Cancer Institute (NCI) is a component of the National Institutes of Health (NIH), one of eight agencies that compose the Public Health Service (PHS) in the Department of Health and Human Services (DHHS). The NCI, established under the National Cancer Act of 1937, is the Federal Government's principal agency for cancer research and training.
The National Cancer Act of 1971 broadened the scope and responsibilities of the NCI and created the National Cancer Program. Over the years, legislative amendments have maintained the NCI authorities and responsibilities and added new information dissemination mandates as well as a requirement to assess the incorporation of state-of-the-art cancer treatments into clinical practice.
The National Cancer Institute coordinates the National Cancer Program, which conducts and supports research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients.
For more information, or to contact National Cancer Institute, see their website at: www.cancer.gov
» Recent News
Menopausal Hormone Use: Questions and Answers
12 Dec 03 | Menopause is the time in a woman's life when menstruation ends. It is part of a biological process that begins, for most women, in their mid-thirties. The ovaries gradually produce lower levels of sex hormones; estrogen and progesterone.
Study Shows Strong Tobacco Control Programs and Policies Can Lower Smoking Rates
18 Nov 03 | A study published today provides the latest evidence that investing in state tobacco control programs can reduce smoking rates. States that were part of the ASSIST intervention program showed a greater reduction in smoking prevalence.
Questions and Answers: ASSIST Evaluation
18 Nov 03 | At the time of the study (1991-1999), the American Stop Smoking Intervention Study (ASSIST) was the largest government-funded demonstration project to help states develop effective strategies to reduce smoking.
NCI, FDA Announce Two New Initiatives As Part of Strategic Partnership
12 Nov 03 | At a Friends of Cancer Research meeting, the National Cancer Institute director and a Food and Drug Administration commissioner announced two new collaborative initiatives to facilitate the development and use of better cancer treatments.
NCI Awards $42 Million to Fund New Cancer Prevention Clinical Trials Consortium to Study Promising New Agents
06 Nov 03 | The National Cancer Institute's Division of Cancer Prevention has created a new consortium of research centers to conduct early-phase cancer prevention clinical trials. Six institutions have been chosen to undertake these critical studies.
Progress Shown in Death Rates From Four Leading Cancers - Decline in Overall Mortality Has Slowed
02 Sep 03 | Death rates from the four most common cancers - lung, breast, prostate, and colorectal - continued to decline in the late 1990s according to new data from the "Annual Report to the Nation on the Status of Cancer, 1975-2000."
Questions and Answers: Annual Report to the Nation on the Status of Cancer 1975-2000, Featuring the Uses of Surveillance Data for Cancer Prevention and Control
02 Sep 03 | This report provides an update of cancer death rates, incidence rates (new cases), and trends in the United States. It also includes information on surveillance data and describes how these data can be used to develop cancer control plans.
Newly Identified Tumor Suppressor Cooperates With p53 to Protect Mice Against Tumors
07 Aug 03 | Researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, have identified a gene that plays an important role in preventing tumors in mice.
Bevacizumab (Avastin™) for Metastatic Colorectal Cancer: Treatment Referral Center Protocol
01 Aug 03 | The National Cancer Institute (NCI) has opened a Treatment Referral Center Protocol that will evaluate bevacizumab in patients who are no longer benefiting from standard treatments for locally advanced or metastatic colorectal cancer.
Questions and Answers: NCI and FDA Announce Joint Program to Streamline Cancer Drug Development
31 Jul 03 | The National Cancer Institute (NCI) and the Food and Drug Administration (FDA) have established this collaboration to enhance the efficiency of clinical research and the scientific evaluation of new cancer medications and diagnostics.
Breast Cancer Risk Among Young Women with Hodgkin Disease
22 Jul 03 | Fifty years ago, Hodgkin disease, a cancer of the lymphatic system, was nearly uniformly fatal. With the introduction of effective treatment regimens, HD is now a potentially curable cancer, associated with an 85% five-year relative survival rate.
Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Trial
22 Jul 03 | In order to determine the long-term effects from vitamin supplements in smokers, ATBC researchers followed the participants for an additional eight years after the trial ended. The findings from this follow-up study are summarized in this fact sheet.
NCI Awards First Funding for Consortium of Cohorts Initiative
09 Jul 03 | The National Cancer Institute (NCI) today announced the funding of a new initiative to pool data and biospecimens from 10 large study populations to conduct research on gene-environment interactions in cancer etiology.
Croyle to Head National Cancer Institute Division of Cancer Control and Population Sciences
01 Jul 03 | The National Cancer Institute (NCI) today announced the appointment of Robert T. Croyle, Ph.D., as director of its Division of Cancer Control and Population Sciences (DCCPS). Croyle has been the acting division director since November 2002.
National Cancer Institute Trial Yields New Data on Colon Cancer Screening Test
01 Jul 03 | New data from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial give fresh insight into the appropriate screening intervals for colorectal cancer after a negative exam.
International Cancer Research Portfolio: New On-Line Tool Will Aid in Cancer Research Collaboration and Planning
26 Jun 03 | Cancer researchers around the world now have a powerful new tool at their fingertips that provides instant access to information on ongoing cancer research supported by cancer funding organizations within the United States and the United Kingdom.
National Cancer Institute Funds Four Centers of Excellence in Cancer Communications Research
25 Jun 03 | The National Cancer Institute (NCI) today announced plans to fund four Centers of Excellence in Cancer Communications Research (CECCR). The CECCR initiative is the centerpiece of NCI's Extraordinary Opportunity in Cancer Communications.
First Prostate Cancer Prevention Drug Found, But Not All Men Benefit
24 Jun 03 | Men who took finasteride, a drug that affects male hormone levels, reduced their chances of getting prostate cancer by nearly 25 percent compared to men who took a placebo, according to results of a national study.
Questions and Answers about the Electromagnetic Fields and Breast Cancer on Long Island Study
24 Jun 03 | In June 2003, scientists reported findings from a population-based study to evaluate whether exposure to electromagnetic fields (EMFs) is associated with increased risk for breast cancer in Long Island (Nassau and Suffolk counties), N.Y.
Prostate Cancer Prevention Trial (PCPT): Questions and Answers
24 Jun 03 | In the Prostate Cancer Prevention Trial (PCPT), 25 percent fewer men taking the drug finasteride developed prostate cancer than men not taking the drug.